Key clinical point: Guideline authors are not reporting financial conflicts of interest.
Major finding: Of 239 guideline authors, 55 did not disclose industry payments.
Study details: A search of The American Society of Clinical Oncology website to identify clinical practice guidelines and review of The Open Payments database.
Disclosures: Dr. Tibau reports nonfinancial support from Pfizer, Roche, and Ipsen outside the submitted work. Dr. Amir reports personal fees for expert testimony from Genentech/Roche and personal fees for advisory boards from Apobiologix, Agendia, and Myriad Genetics outside the submitted work. No other disclosures were reported.
Saleh et. al. 2019 July 29 doi: 10.1002/cncr.32408.